INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New precision drug targets genetic driver in tough cancers
Disease control CompletedThis study tested a new, highly targeted drug called RLY-4008 in people with advanced cancers, focusing on bile duct cancer. The main goals were to find a safe and effective dose and to see if the drug could shrink tumors in patients whose cancers have a specific genetic change c…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Bubble-Popping ultrasound could boost cancer treatment
Diagnosis CompletedThis study tested a special ultrasound scan that uses tiny gas bubbles to see inside liver tumors. The goal was to see if this scan could predict how well a targeted radiation treatment would work for bile duct cancer. Researchers also tested if using the ultrasound to 'pop' thes…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Feb 25, 2026 15:07 UTC